论文部分内容阅读
目的 :探讨奥扎格雷钠治疗进展性血栓性卒中的临床疗效。方法 :应用奥扎格雷钠治疗进展性血栓性卒中 68例 ,另设对照组 60例 ,对两组患者治疗前、后进行神经功能缺损评分和临床疗效评定。结果 :奥扎格雷钠治疗组用药前、后神经功能缺损评分比对照组明显降低 (P <0 .0 5 ) ,治疗后 2 1天奥扎格雷钠治疗组的治愈率、总有效率 (分别为 2 6 4% ,75 % )明显高于对照组 (分别为 2 1 6% ,5 8% ) ,两组比较差异有显著意义 (均P <0 .0 0 5 )。结论 :奥扎格雷钠治疗进展性血栓性卒中有良好的临床疗效。
Objective: To investigate the clinical efficacy of ozagrel sodium in the treatment of advanced thrombotic stroke. Methods: 68 cases of progressive thrombotic stroke were treated with ozagrel sodium and 60 cases of control group. Neurological deficit score and clinical curative effect were evaluated before and after treatment. Results: The score of neurological deficits in the ozagrel sodium treatment group was significantly lower than that in the control group before and after treatment (P <0.05), and the cure rate and total effective rate (26.4%, 75%) was significantly higher than that of the control group (21.6% and 58% respectively). There was significant difference between the two groups (all P <0.05). Conclusion: Ozagrel sodium has a good clinical effect in the treatment of advanced thrombotic stroke.